# Deficits in episodic memory and executive functions in relation to CB1 receptor availability in Parkinson's disease.

- **DOI:** [10.1177/1877718x261457830](https://doi.org/10.1177/1877718x261457830)
- **Rating:** Sound (3.2 out of 5)
- **Verdict:** A useful second-tracer replication links CB1 receptor availability to selected cognitive scores in Parkinson’s disease, but limited confounding control constrains interpretation.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1177%2F1877718x261457830

## Key claims

1. Decreased CB1R availability in PD patients is correlated with episodic memory impairment and executive dysfunction, suggesting that the ECS has a role in the pathophysiology of cognitive symptoms in PD.
   - Support: Tentative
   - Type: Primary finding
   - Basis: cross-sectional associations in a cognitively preserved sample cannot establish impairment or a pathophysiological role
   - Location: Abstract, Conclusions
2. PD patients with poorer performance in episodic memory tests showed lower CB1R availability, particularly in the cingulate, temporal, and visual cortices, and thalami.
   - Support: Supported
   - Type: Secondary
   - Basis: three episodic-memory measures showed corrected associations, though the small cross-sectional sample limits precision
   - Location: Abstract, Results; Results, Figure 1
3. PD patients with poorer executive functioning showed lower CB1R availability predominantly in the insulae, caudate nuclei, thalami, brainstem, and temporal cortices.
   - Support: Tentative
   - Type: Secondary
   - Basis: the broad executive claim rests on TMT B-A while three other executive measures were null
   - Location: Abstract, Results; Results, Figure 2
4. No relationship was found between CB1R availability and language function, visuospatial function, or working memory capacity.
   - Support: Supported
   - Type: Secondary
   - Basis: the specified tests were null, but the sample was underpowered to establish absence of association
   - Location: Abstract, Results; Results, null-results paragraph

## Strengths

- **Independent tracer extends sparse evidence** The study tests the CB1R–cognition relationship with [18F]FMPEP-d2 and absolute VT, complementing the earlier [18F]MK9470 study that used proportional scaling.
  - Dimension: contribution
  - Location: Introduction; Discussion, comparison with the prior PET study
- **Multiple sensitivity analyses reported transparently** The paper reports voxelwise and across-test multiplicity control, partial-volume correction, exclusion of escitalopram users, and winsorized versus unwinsorized TMT B-A analyses.
  - Dimension: methodological rigour
  - Location: Methods, Statistical Analyses; Results, Figures 1–2; Discussion, medication and atrophy paragraphs
- **Limitations inform the final interpretation** Amyloid co-pathology, medication, atrophy, small sample size, preserved cognition, and the need for longitudinal follow-up are connected to the scope of the conclusions.
  - Dimension: positioning
  - Location: Discussion, limitations and Conclusion

## Limitations

- **Confounding control remains too limited** The principal PET regressions include LEDD but not age, education, disease severity, depressive symptoms, or AD biomarker status, despite plausible relationships with cognition or CB1R availability.
  - Dimension: methodological rigour
  - Location: Methods, Statistical Analyses; Results, CSF Biomarkers
- **Headline framing exceeds observed cognition** The title and Abstract refer to deficits, impairment, and executive dysfunction, although Table 2 reports no PD–control cognitive differences and only TMT B-A was significant among four executive measures.
  - Dimension: reporting
  - Location: Title; Abstract; Results, Table 2 and null-results paragraph
- **Regional specificity is difficult to establish** The analysis used absolute VT without global normalization and produced clusters spanning extensive cortical and subcortical areas. The cluster-display threshold is not specified beyond showing significant clusters.
  - Dimension: methodological rigour
  - Location: Methods, Statistical Analyses; Results, Figures 1–2

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Clean. The reported numbers and statistics are consistent with the stated results.
- **Reporting and transparency:** Noted. The acquisition-to-modelling description leaves the handling of a scan gap unexplained, and the numerical cluster-extent display threshold is not reported; neither omission establishes that the reported associations change.
  - Ethics approval: declared · Data availability: declared
- **Reference integrity:** Clean
  - 80 references in manuscript
  - 80 of 80 checkable references found in an index
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
